Results 71 to 80 of about 19,433 (209)

Clinical and biochemical parameters at baseline in patients who developed hypophosphatemia compared with patients who did not develop hypophosphatemia.

open access: yes, 2016
Clinical and biochemical parameters at baseline in patients who developed hypophosphatemia compared with patients who did not develop hypophosphatemia.
Philipp Würtinger (3373136)   +11 more
core   +1 more source

A case of hypophosphatemia and elevated intact fibroblast growth factor 23 levels after short-term saccharated ferric oxide administration in a young woman and database analysis of adverse drug reactions in Japan

open access: yesBone Reports
Intravenous iron replacement therapy is a common treatment for iron deficiency. Commonly used agents in this treatment include ferric carboxymaltose, ferric derisomaltose, and saccharated ferric oxide (SFO).
Teruhisa Kinoshita   +5 more
doaj   +1 more source

Assessing Clinical Severity and Prognosis in Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa Using the Albumin‐Globulin Ratio

open access: yesEuropean Eating Disorders Review, Volume 34, Issue 5, Page 1193-1208, September 2026.
ABSTRACT Objective The albumin‐globulin ratio (AGR) is a biochemical marker reflecting nutritional and inflammatory status, with significant prognostic value in chronic conditions. This study examined its association with clinical/biochemical markers in adolescents with anorexia nervosa (AN) and atypical AN (AAN).
Eylem Şerife Kalkan   +5 more
wiley   +1 more source

Tumor-induced hypophosphatemia

open access: yesIndian Journal of Nephrology, 2017
Significant hypophosphatemia is commonly due to Vitamin D deficiency. Any sporadic onset of hypophosphatemia in adults warrants workup to identify alternate causes. Hypophosphatemia may also be the only manifestation of an occult malignancy. A high index of clinical suspicion can help diagnose such conditions in early stages.
Mulani, M.   +3 more
openaire   +2 more sources

Blood disorders caused by hypophosphatemia in dairy cows [PDF]

open access: yes
Objective: To describe the main blood disorders caused by hypophosphatemia (low level of phosphorous (P) in the blood) in dairy cows. Design/methodology/approach: An analysis of published research on blood disorders caused by hypophosphatemia in dairy ...
Trejo Téllez, Libia Iris   +5 more
core   +2 more sources

Hypophosphatemia after hemodialysis and its association with some clinical complications in patients with chronic kidney disease

open access: yesCaspian Journal of Internal Medicine, 2022
Background: Beyond the adverse effects of hyperphosphatemia in patients with chronic kidney disease (CKD(, hypophosphatemia has also been proposed as a common challenge after dialysis.
Mohammadreza Ardalan   +5 more
doaj  

Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report

open access: yes, 2013
Shereen Elazzazy,1 Hager A El-Geed,2 Sumaya Al Yafei11Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, 2College of Pharmacy, Qatar University, Doha, QatarAbstract: The effect of the ESHAP (etoposide ...
El-Geed HA, Al Yafei S, Elazzazy S
core  

Minimally Invasive Intramedullary Fixation of Middle third clavicular Fractures Through the Medial Entry by Titanium Elastic Nailing System (TENS) [PDF]

open access: yesAl-Azhar International Medical Journal
Background: Serum phosphate levels below 2.5 mg/dl are considered hypophosphatemia, and they are common in critically sick cases. Hypophosphatemia can impair respiratory drive, muscle contractility, and myocardial function.Aim and objectives: To evaluate
doaj   +1 more source

Hypophosphatemia in critical care in adult patients (literature review)

open access: yesВестник анестезиологии и реаниматологии
Hypophosphatemia is a common metabolic disorder in intensive care unit (ICU) patients. A deficiency in serum phosphate can develop primarily due to three reasons: reduced intestinal phosphate absorption, redistribution of phosphate from the extracellular
K. S. Kulikova, D. K. Azovskiy
doaj   +1 more source

Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment. [PDF]

open access: yes, 2016
© 2016, International Osteoporosis Foundation and National Osteoporosis Foundation. Summary: Cutaneous skeletal hypophosphatemia syndrome (CSHS), caused by somatic RAS mutations, features excess fibroblast growth factor-23 (FGF23) and skeletal dysplasia.
Boyce, AM   +49 more
core   +1 more source

Home - About - Disclaimer - Privacy